ATE232398T1 - Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptid - Google Patents
Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptidInfo
- Publication number
- ATE232398T1 ATE232398T1 AT99972932T AT99972932T ATE232398T1 AT E232398 T1 ATE232398 T1 AT E232398T1 AT 99972932 T AT99972932 T AT 99972932T AT 99972932 T AT99972932 T AT 99972932T AT E232398 T1 ATE232398 T1 AT E232398T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- peptide
- anticancer agent
- composition containing
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9815073A FR2786398B1 (fr) | 1998-11-30 | 1998-11-30 | Composition pharmaceutique anti-cancereuse et anti-chimioresistance comprenant un agent anticancereux et au moins un peptide |
| PCT/FR1999/002939 WO2000032237A1 (fr) | 1998-11-30 | 1999-11-26 | Composition pharmaceutique comprenant un agent anti-cancereux et au moins un peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE232398T1 true ATE232398T1 (de) | 2003-02-15 |
Family
ID=9533369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99972932T ATE232398T1 (de) | 1998-11-30 | 1999-11-26 | Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptid |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7527792B1 (de) |
| EP (1) | EP1135169B1 (de) |
| JP (1) | JP2002538080A (de) |
| AT (1) | ATE232398T1 (de) |
| AU (1) | AU769766B2 (de) |
| CA (1) | CA2352134A1 (de) |
| DE (1) | DE69905392T2 (de) |
| DK (1) | DK1135169T3 (de) |
| ES (1) | ES2192420T3 (de) |
| FR (1) | FR2786398B1 (de) |
| IL (2) | IL143012A0 (de) |
| PT (1) | PT1135169E (de) |
| WO (1) | WO2000032237A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0103110D0 (en) | 2000-08-25 | 2001-03-28 | Aventis Pharma Inc | A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1 |
| FR2821272B1 (fr) * | 2001-02-23 | 2004-12-17 | Synt Em | Composes constitues d'une molecule analgesique liee a un vecteur capable de vectoriser ladite molecule a travers la barriere hematoencephalique et compositions pharmaceutiques les contenant |
| FR2830016B1 (fr) * | 2001-09-27 | 2004-06-25 | Synt Em | Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau |
| CA2461575A1 (en) | 2001-10-16 | 2003-04-24 | Synt:Em S.A. | Use of peptide vectors to improve the immune response to antigens |
| FR2840810B1 (fr) * | 2002-06-18 | 2005-02-11 | Synt Em | Composition pour le transfert de molecules therapeutiques dans les poumons et leur utilisation pour le traitement des cancers du poumon et des maladies pulmonaires |
| FR2968662B1 (fr) | 2010-12-10 | 2013-11-22 | Roussy Inst Gustave | Nouveaux derives d'oxazaphosphorines pre-activees, utilisation et methode de preparation |
| EP3217947B1 (de) | 2014-11-12 | 2022-03-09 | University of Mississippi Medical Center | Auf die nieren gerichtete wirkstofffreisetzungssysteme |
| US11564991B2 (en) | 2014-11-12 | 2023-01-31 | University Of Mississippi Medical Center | Molecular-size of elastin-like polypeptide delivery system for therapeutics modulates intrarenal deposition and bioavailability |
| KR102015524B1 (ko) | 2016-12-26 | 2019-08-29 | 인터올리고 주식회사 | 압타머-약물 콘쥬게이트 및 그 용도 |
| US11248038B2 (en) | 2019-03-29 | 2022-02-15 | University Of Mississippi Medical Center | Molecular-size of elastin-like polypeptide delivery system for therapeutics modulates intrarenal deposition and bioavailability |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5608039A (en) * | 1990-10-12 | 1997-03-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Single chain B3 antibody fusion proteins and their uses |
| FR2739621B1 (fr) * | 1995-10-05 | 1997-12-05 | Centre Nat Rech Scient | Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives |
| US5843903A (en) * | 1995-11-27 | 1998-12-01 | The Administrators Of The Tulane Educational Fund | Targeted cytotoxic anthracycline analogs |
| WO1998046250A1 (en) * | 1997-04-14 | 1998-10-22 | The Regents Of The University Of California | Peptide antiestrogen compositions and methods for treating breast cancer |
| FR2767323B1 (fr) * | 1997-08-12 | 2001-01-05 | Synt Em | Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives |
| FR2830016B1 (fr) | 2001-09-27 | 2004-06-25 | Synt Em | Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau |
-
1998
- 1998-11-30 FR FR9815073A patent/FR2786398B1/fr not_active Expired - Fee Related
-
1999
- 1999-11-26 CA CA002352134A patent/CA2352134A1/fr not_active Abandoned
- 1999-11-26 WO PCT/FR1999/002939 patent/WO2000032237A1/fr active IP Right Grant
- 1999-11-26 IL IL14301299A patent/IL143012A0/xx active IP Right Grant
- 1999-11-26 JP JP2000584926A patent/JP2002538080A/ja active Pending
- 1999-11-26 ES ES99972932T patent/ES2192420T3/es not_active Expired - Lifetime
- 1999-11-26 DE DE69905392T patent/DE69905392T2/de not_active Expired - Lifetime
- 1999-11-26 PT PT99972932T patent/PT1135169E/pt unknown
- 1999-11-26 EP EP99972932A patent/EP1135169B1/de not_active Expired - Lifetime
- 1999-11-26 US US09/856,940 patent/US7527792B1/en not_active Expired - Fee Related
- 1999-11-26 AT AT99972932T patent/ATE232398T1/de not_active IP Right Cessation
- 1999-11-26 AU AU13911/00A patent/AU769766B2/en not_active Ceased
- 1999-11-26 DK DK99972932T patent/DK1135169T3/da active
-
2001
- 2001-05-07 IL IL143012A patent/IL143012A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1391100A (en) | 2000-06-19 |
| DE69905392D1 (de) | 2003-03-20 |
| FR2786398A1 (fr) | 2000-06-02 |
| EP1135169A1 (de) | 2001-09-26 |
| US7527792B1 (en) | 2009-05-05 |
| PT1135169E (pt) | 2003-06-30 |
| JP2002538080A (ja) | 2002-11-12 |
| DE69905392T2 (de) | 2003-10-09 |
| IL143012A (en) | 2007-05-15 |
| AU769766B2 (en) | 2004-02-05 |
| ES2192420T3 (es) | 2003-10-01 |
| CA2352134A1 (fr) | 2000-06-08 |
| EP1135169B1 (de) | 2003-02-12 |
| DK1135169T3 (da) | 2003-06-10 |
| FR2786398B1 (fr) | 2002-12-27 |
| IL143012A0 (en) | 2002-04-21 |
| WO2000032237A1 (fr) | 2000-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962154A (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
| ATE208382T1 (de) | Konjugate von cis-docosahexaensäure und paclitaxel | |
| GEP20043375B (en) | APRIL-Receptor (BCMA) and Use Thereof | |
| BR9607260A (pt) | Utilização de aerogéis em agricultura | |
| TR200100824T2 (tr) | İleumda safra asidi taşınmasının ve taurokolat alımının inhibitörleri olarak aktifliğe sahip benzotiepinler | |
| DE69912870D1 (de) | Kosmetische oder dermatologische Zusammensetzung, enthaltend zumindest ein natürliches oder rekombinantes Seidenprotein von Arachniden oder ein analoges Protein | |
| PL329802A1 (en) | Derivatives of androstene | |
| ATE272628T1 (de) | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen | |
| ZA963959B (en) | Tetralin compounds with improved mdr activity | |
| ATE232398T1 (de) | Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptid | |
| NO934706L (no) | Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner | |
| PT1109571E (pt) | Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos | |
| ATE253820T1 (de) | Wirkstoffhaltige komposition sowie deren herstellung und verwendung | |
| SE9802937D0 (sv) | Novel compounds | |
| KR100292396B1 (de) | ||
| DK0865271T3 (da) | Stabiliserede solbeskyttelsespræparater | |
| UY26431A1 (es) | Quimioterapia de combinación | |
| ZA986720B (en) | Photoresponsive sunscreen compositions | |
| DE69815840D1 (de) | Verwendung von tall-104 zellen in kombination mit adriamyzin oder cisplatin zur behandlung von malignen tumoren | |
| DE60239670D1 (de) | Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis | |
| ES2190581T3 (es) | 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico. | |
| TR199901237T2 (xx) | Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�. | |
| BR9805928A (pt) | Composição cosmética ou farmacêutica e processos paraa proteger as células da pele de pano por uv, e para evitar o fotoenvelhicemento. | |
| EP0970688A3 (de) | Verwendung von Eisen-Titan-Mischoxiden zur Verstärkung der Lichtschutzleistung kosmetischer oder dermatologischer Lichtschutzmittel | |
| NZ506005A (en) | Recombinant proteins derived from hgf and msp |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1135169 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |